All Stories

  1. Optimizing Hydroxyurea Treatment for Sickle Cell Disease Patients: The Pharmacokinetic Approach

    Article • Journal of Clinical Medicine, October 2019, MDPI AG

    Dr Véronique Kemmel

  2. Protective effect of 4-Phenylbutyrate against proteolipid protein mutation-induced endoplasmic reticulum stress and oligodendroglial cell death

    Article • Neurochemistry International, September 2018, Elsevier

    Dr Véronique Kemmel

  3. Evidence for effective structure-based neuromodulatory effects of new analogues of neurosteroid allopregnanolone

    Article • Journal of Neuroendocrinology, February 2018, Wiley

    Dr Véronique Kemmel

  4. Rifampicin reverses nicardipine effect inducing uncontrolled essential hypertension

    Article • Fundamental and Clinical Pharmacology, July 2017, Wiley

    Dr Véronique Kemmel

  5. EPT-13RAPIRI I – PHASE I STUDY OF DAILY ORAL RAPAMYCIN AND INTRAVENOUS IRINOTECAN IN CHILDREN WITH A RECURRENT/REFRACTORY MALIGNANT SOLID TUMOR: GOOD TOLERANCE AND PROMISING RESULTS IN BRAIN TUMORS - A REPORT FROM THE SOCIÉTÉ FRANÇAISE DES CANCERS ET L...

    Article • Neuro-Oncology, June 2016, Oxford University Press (OUP)

    Dr Véronique Kemmel

  6. Neurophysiological responses to unpleasant stimuli (acute electrical stimulations and emotional pictures) are increased in patients with schizophrenia

    Article • Scientific Reports, March 2016, Nature

    Dr Véronique Kemmel

  7. Skeletal muscle ischemia-reperfusion injury and cyclosporine A in the aging rat

    Article • Fundamental and Clinical Pharmacology, February 2016, Wiley

    Dr Véronique Kemmel

  8. Management of Tacrolimus-Telaprevir Drug-Drug Interaction in a Liver Transplant Patient With Hepatitis C Virus

    Article • Transplantation, September 2015, Wolters Kluwer Health

    Dr Véronique Kemmel

  9. Analyse pharmacocinétique comparée de l’infiltration intra-articulaire et périnerveuse fémorale continue de ropivacaïne pour arthroplastie totale de genou

    Article • Anesthésie & Réanimation, September 2015, Elsevier

    Dr Véronique Kemmel

  10. Mitomycin C Pharmacokinetics as Predictor of Severe Neutropenia in Hyperthermic Intraperitoneal Therapy

    Article • Annals of Surgical Oncology, June 2015, Springer Science + Business Media

    Dr Véronique Kemmel

  11. Poster #T67 ARE PATIENTS WITH SCHIZOPHRENIA ABNORMALLY SENSITIVE TO PAIN?

    Article • Schizophrenia Research, April 2014, Elsevier

    Dr Véronique Kemmel

  12. Gamma-hydroxybutyrate, acting through an anti-apoptotic mechanism, protects native and amyloid-precursor-protein-transfected neuroblastoma cells against oxidative stress-induced death

    Article • Neuroscience, March 2014, Elsevier

    Dr Véronique Kemmel

  13. Xanthurenic Acid Binds to Neuronal G-Protein-Coupled Receptors That Secondarily Activate Cationic Channels in the Cell Line NCB-20

    Article • PLoS ONE, November 2012, PLOS

    Dr Véronique Kemmel

  14. Pharmacokinetic Behavior and Appraisal of Intravenous Busulfan Dosing in Infants and Older Children

    Article • Therapeutic Drug Monitoring, April 2012, Wolters Kluwer Health

    Dr Véronique Kemmel

  15. Ventricular bigeminy associated with voriconazole, methadone and esomeprazole

    Article • International Journal of Clinical Pharmacy, November 2011, Springer Science + Business Media

    Dr Véronique Kemmel

  16. Conditioning the CO2 for pneumoperitoneal insufflation: Combination of humidification, heating and drug delivery

    Article • European Journal of Anaesthesiology, June 2010, Wolters Kluwer Health

    Dr Véronique Kemmel

  17. Calcium and cAMP signaling induced by gamma-hydroxybutyrate receptor(s) stimulation in NCB-20 neurons

    Article • Neuroscience, April 2010, Elsevier

    Dr Véronique Kemmel

  18. A single acute pharmacological dose of γ-hydroxybutyrate modifies multiple gene expression patterns in rat hippocampus and frontal cortex

    Article • Physiological Genomics, April 2010, American Physiological Society

    Dr Véronique Kemmel

  19. Abnormal Nociception and Opiate Sensitivity of STOP Null Mice Exhibiting Elevated Levels of the Endogenous Alkaloid Morphine

    Article • Molecular Pain, January 2010, SAGE Publications

    Dr Véronique Kemmel

  20. Pharmacological doses of gamma-hydroxybutyrate (GHB) potentiate histone acetylation in the rat brain by histone deacetylase inhibition

    Article • Neuropharmacology, August 2009, Elsevier

    Dr Véronique Kemmel

  21. Xanthurenic acid distribution, transport, accumulation and release in the rat brain

    Article • Journal of Neurochemistry, May 2008, Wiley

    Dr Véronique Kemmel

  22. Endogenous Morphine in SH-SY5Y Cells and the Mouse Cerebellum

    Article • PLoS ONE, February 2008, PLOS

    Dr Véronique Kemmel

  23. Cloning and functional characterization of a gamma-hydroxybutyrate receptor identified in the human brain

    Article • The FASEB Journal, March 2007, Federation of American Societies For Experimental Biology (FASEB)

    Dr Véronique Kemmel

  24. 40 Intérêt de l’étude de la pharmacocinétique de la ciclosporine après greffe pulmonaire

    Article • Revue des Maladies Respiratoires, January 2007, Elsevier

    Dr Véronique Kemmel

  25. Immunohistochemical localization of a GHB receptor-like protein isolated from rat brain

    Article • The Journal of Comparative Neurology, January 2006, Wiley

    Dr Véronique Kemmel

  26. Mécanismes d’action d’un médicament détourné : le γ-hydroxybutyrate

    Article • médecine/sciences, March 2005, EDP Sciences

    Dr Véronique Kemmel

  27. γ-hydroxybutyrate receptor function determined by stimulation of rubidium and calcium movements from NCB-20 neurons

    Article • Neuroscience, February 2003, Elsevier

    Dr Véronique Kemmel

  28. Gamma-hydroxybutyric acid as a signaling molecule in brain

    Article • Alcohol, April 2000, Elsevier

    Dr Véronique Kemmel

  29. Immunohistochemical studies of the localization of neurons containing the enzyme that synthesizes dopamine, GABA, or ?-hydroxybutyrate in the rat substantia nigra and striatum

    Article • The Journal of Comparative Neurology, January 2000, Wiley

    Dr Véronique Kemmel

  30. γ-hydroxybutyrate receptor function studied by the modulation of nitric oxide synthase activity in rat frontal cortex punches

    Article • Biochemical Pharmacology, December 1999, Elsevier

    Dr Véronique Kemmel

  31. Neurochemical and electrophysiological evidence for the existence of a functional γ-hydroxybutyrate system in NCB-20 neurons

    Article • Neuroscience, June 1998, Elsevier

    Dr Véronique Kemmel

  32. Sulpiride, but not haloperidol, up-regulates γ-hydroxybutyrate receptors in vivo and in cultured cells

    Article • European Journal of Pharmacology, April 1998, Elsevier

    Dr Véronique Kemmel

  33. The role of γ-hydroxybutyrate in brain function

    Article • Taylor & Francis

    Dr Véronique Kemmel